Celgene Acquires Abraxis for $2.9 Billion
Celgene Acquires Abraxis for $2.9 Billion
Celgene’s purchase expands the company into the solid tumor cancer drug market.
Read more on TheStreet.com
- Breast Cancer Awareness
- Breast Cancer Awareness Month
- Breast Cancer Bracelets
- Breast Cancer Chemotherapy
- Breast Cancer Doctors
- Breast Cancer Facts
- Breast Cancer In Men
- Breast Cancer Information
- Breast Cancer Lump
- Breast Cancer Mammogram
- Breast Cancer Organizations
- Breast Cancer Pain
- Breast Cancer Pink Ribbon
- Breast Cancer Pins
- Breast Cancer Questions & Answers
- Breast Cancer Radiation
- Breast Cancer Recovery
- Breast Cancer Research
- Breast Cancer Risks
- Breast Cancer Screening
- Breast Cancer Staging
- Breast Cancer Survivors
- Breast Cancer Symptoms
- Breast Cancer Treatment
- Breast Cancer Treatment Options
- Breast Cancer Tumor
- DCIS Breast Cancer
- Early Age Breast Cancer
- Genetic Testing For Breast Cancer
- High Risk Breast Cancer
- Metastatic Breast Cancer
Comments